American Action Forum Issues Commentary: Novel Drug and Biologic Development - Impacts of Recent FDA Regulatory Efforts
November 25, 2025
November 25, 2025
WASHINGTON, Nov. 25 -- The American Action Forum issued the following commentary on Nov. 24, 2025:
* * *
Novel Drug and Biologic Development: Impacts of Recent FDA Regulatory Efforts
By Nicolas Montenegro
Executive Summary
* Under its current leadership, the Food and Drug Administration (FDA) has initiated sweeping reforms intended to optimize the development and approval process of novel drugs and biologics.
* These r . . .
* * *
Novel Drug and Biologic Development: Impacts of Recent FDA Regulatory Efforts
By Nicolas Montenegro
Executive Summary
* Under its current leadership, the Food and Drug Administration (FDA) has initiated sweeping reforms intended to optimize the development and approval process of novel drugs and biologics.
* These r . . .